Switch to: References

Add citations

You must login to add citations.
  1. Medicalization of Sexual Desire.Jacob Stegenga - 2021 - European Journal of Analytic Philosophy 17 (2):(SI5)5-34.
    Medicalisation is a social phenomenon in which conditions that were once under legal, religious, personal or other jurisdictions are brought into the domain of medical authority. Low sexual desire in females has been medicalised, pathologised as a disease, and intervened upon with a range of pharmaceuticals. There are two polarised positions on the medicalisation of low female sexual desire: I call these the mainstream view and the critical view. I assess the central arguments for both positions. Dividing the two positions (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Contested psychiatric ontology and feminist critique.Katherine Angel - 2012 - History of the Human Sciences 25 (4):3-24.
    In this article I discuss the emergence of Female Sexual Dysfunction (FSD) within American psychiatry and beyond in the postwar period, setting out what I believe to be important and suggestive questions neglected in existing scholarship. Tracing the nomenclature within successive editions of the American Psychiatric Association’s Diagnostic and Statistical Manual ( DSM), I consider the reification of the term ‘FSD’, and the activism and scholarship that the rise of the category has occasioned. I suggest that analysis of FSD benefits (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Marketing Silence, Public Health Stigma and the Discourse of Risky Gay Viagra Use in the US.Emily Wentzell - 2011 - Body and Society 17 (4):105-125.
    This article analyzes the rise and fall of a public health ‘fact’ in the US: the assertion that gay men’s Viagra use is inherently recreational and increases STD risk. Extending the science studies argument that drug development and marketing entail the construction of new publics, this article shows how strategic drug marketing silences can also constitute new populations of users. It shows how Viagra marketing’s silence about gay users, which facilitated legitimization of the drug as an aid for companionate heterosexuality, (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Potency in All the Right Places: Viagra as a Technology of the Gendered Body.Laura Mamo & Jennifer R. Fishman - 2001 - Body and Society 7 (4):13-35.
    New pharmacological therapies, often dubbed `lifestyle drugs', demonstrate the enactment of yet another interface between technologies and bodies that promises a re-fashioning of the body with transformative, life-enhancing results. This article analyzes the emergence of one lifestyle drug, Viagra, from a technoscience studies perspective, conceptualizing Viagra as a new medical technology of the body. Through an analysis of promotional materials for Viagra, we argue that this pharmaceutical device performs ideological work through its discursive scripts that serves to reinforce and augment (...)
    Download  
     
    Export citation  
     
    Bookmark   13 citations  
  • The sex/gender perplex.Anne Fausto-Sterling - 2000 - Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 31 (4):637-646.
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Intersex and informed consent: How physicians' rhetoric constrains choice.J. David Hester - 2004 - Theoretical Medicine and Bioethics 25 (1):21-49.
    When a child is born with ambiguousgenitalia it is declared a psychosocialemergency, and the policy first proposed byJohn Money andadapted by the American Academy of Pediatrics requires determination ofunderlying condition, selection of gender,surgical intervention, and a commitment by allparties to accept the ``real sex'' of thepatient, all no later than 18–24 months,preferably earlier. Ethicists have recentlyquestioned this protocol on several grounds:lack of medical necessity, violation ofinformed consent, uncertainty of standards ofsuccess, among others. This suggests that thefaults in the protocol can (...)
    Download  
     
    Export citation  
     
    Bookmark   4 citations  
  • Distress, disease, desire: perspectives on the medicalisation of premature ejaculation.Ylva Söderfeldt, Adam Droppe & Tim Ohnhäuser - 2017 - Journal of Medical Ethics 43 (12):865-866.
    The discovery that certain selective serotonin reuptake inhibitors delay ejaculation and the later development and approval of dapoxetine as an on-demand treatment option has led to a dramatic increase in medical interest in premature ejaculation. This paper analyses the diagnostic criteria and the discussion within the medical community about suitable treatments against the backdrop of theories of science, sex and gender. Our conclusion is that the diagnosis itself and the suggested treatments contribute to normative models of sexual conduct and therefore (...)
    Download  
     
    Export citation  
     
    Bookmark